跳至主要内容
临床试验/NCT01977352
NCT01977352已完成4 期

Comparison of Cumulative Opioid Consumption After Interscalene Brachial Plexus Block With Liposomal Bupivacaine (Exparel; 88 mg in 20 cc) Versus Bupivacaine 0.25% for Arthroscopic Shoulder Surgery

St. Luke's-Roosevelt Hospital Center1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
42
试验地点
1
主要终点
Total Opioid Consumption

研究概览

简要总结

The purpose of this study is to compare the quality and duration of pain relief after shoulder surgery provided by a single injection of liposomal bupivacaine versus standard bupivacaine when administered as an interscalene brachial plexus block. It is hypothesized that the liposomal bupivacaine formulation will provide more effective pain relief than standard bupivacaine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking adults (age >17 years) of American Society of Anesthesiologists (ASA) I-III physical class scheduled for elective arthroscopic shoulder surgery will be eligible to participate regardless of race/ethnicity.

排除标准

  • Subjects will not be eligible for this trial if they report a history of an allergy to a local anesthetic, baseline neurological deficit, a medical condition that would make it difficult to assess sensory distribution or communicate with the staff, a recent history (< 3 months) of drug or alcohol abuse, concomitant opioid therapy, or a preexisting coagulation disorder.

研究组 & 干预措施

Bupivacaine 0.25%

Active Comparator

20 cc of bupivacaine 0.25%

干预措施: Liposomal bupivacaine (Drug)

Liposomal bupivacaine

Experimental

liposomal bupivacaine (EXPAREL®; 88 mg in 20 cc)

干预措施: Bupivacaine 0.25% (Drug)

结局指标

主要结局

Total Opioid Consumption

时间窗: Post op Day 1, post op Day 2, post op day 3, post op 1 week

Compare total opioid consumption up to 1 week post operatively between patients receiving bupivacaine 0.25% (20 cc) and liposomal bupivacaine (EXPAREL®; 88 mg in 20 cc) for interscalene brachial plexus block.

次要结局

  • Time to Discharge Home(72 hours)
  • Quality of Analgesia(Post op Day 1, post op Day 2, post op day 3, post op 1 week)
  • Sensory and Motor Block(at 20 min and at 1 hour)
  • Time to First Pain Medicine(72 hours)
  • Incidence of Postoperative Nausea and Vomiting(72 hours)
  • Sleep Quality(Post op Day 1, post op Day 2, post op day 3, post op 1 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验